These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 36071550

  • 1. The High Relevance of 21-Deoxycortisol, (Androstenedione + 17α-Hydroxyprogesterone)/Cortisol, and 11-Deoxycortisol/17α-Hydroxyprogesterone for Newborn Screening of 21-Hydroxylase Deficiency.
    Watanabe K, Tsuji-Hosokawa A, Hashimoto A, Konishi K, Ishige N, Yajima H, Sutani A, Nakatani H, Gau M, Takasawa K, Tajima T, Hasegawa T, Morio T, Kashimada K.
    J Clin Endocrinol Metab; 2022 Nov 25; 107(12):3341-3352. PubMed ID: 36071550
    [Abstract] [Full Text] [Related]

  • 2. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
    Zhan X, Han L, Qiu W, Gu X, Guo J, Chang S, Wang Y, Zhang H.
    Steroids; 2022 Sep 25; 185():109056. PubMed ID: 35660382
    [Abstract] [Full Text] [Related]

  • 3. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J.
    J Clin Endocrinol Metab; 2007 Jul 25; 92(7):2581-9. PubMed ID: 17456574
    [Abstract] [Full Text] [Related]

  • 4. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Steroids Androstenedione, Dehydroepiandrosterone, 11-Deoxycortisol, 17-Hydroxyprogesterone, and Testosterone.
    Munar A, Clinton Frazee C, Garg U.
    Methods Mol Biol; 2022 Jul 25; 2546():451-457. PubMed ID: 36127612
    [Abstract] [Full Text] [Related]

  • 5. Steroid profiling for the diagnosis of congenital adrenal hyperplasia by microbore ultra-performance liquid chromatography-tandem mass spectrometry.
    Feng D, Wang Z, Li H, Shi X, Zou L, Kong H, Xu Z, Yu C, Hu C, Xu G.
    Clin Chim Acta; 2023 Mar 15; 543():117304. PubMed ID: 36958425
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry.
    Magnisali P, Chalioti MB, Livadara T, Mataragas M, Paliatsiou S, Malamitsi-Puchner A, Moutsatsou P.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun 01; 879(19):1565-72. PubMed ID: 21514253
    [Abstract] [Full Text] [Related]

  • 7. Determination of a steroid profile in heel prick blood using LC-MS/MS.
    Boelen A, Ruiter AF, Claahsen-van der Grinten HL, Endert E, Ackermans MT.
    Bioanalysis; 2016 Jun 01; 8(5):375-84. PubMed ID: 26891684
    [Abstract] [Full Text] [Related]

  • 8. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
    Janzen N, Riepe FG, Peter M, Sander S, Steuerwald U, Korsch E, Krull F, Müller HL, Heger S, Brack C, Sander J.
    Horm Res Paediatr; 2012 Jun 01; 77(3):195-9. PubMed ID: 22508345
    [Abstract] [Full Text] [Related]

  • 9. Dried Blood Spot Multiplexed Steroid Profiling Using Liquid Chromatography Tandem Mass Spectrometry in Korean Neonates.
    Choi R, Park HD, Oh HJ, Lee K, Song J, Lee SY.
    Ann Lab Med; 2019 May 01; 39(3):263-270. PubMed ID: 30623618
    [Abstract] [Full Text] [Related]

  • 10. 21-Deoxycortisol is a Key Screening Marker for 21-Hydroxylase Deficiency.
    Held PK, Bialk ER, Lasarev MR, Allen DB.
    J Pediatr; 2022 Mar 01; 242():213-219.e1. PubMed ID: 34780778
    [Abstract] [Full Text] [Related]

  • 11. Reassessment of predictive values of ACTH-stimulated serum 21-deoxycortisol and 17-hydroxyprogesterone to identify CYP21A2 heterozygote carriers and nonclassic subjects.
    Costa-Barbosa FA, Carvalho VM, Oliveira KC, Vieira JGH, Kater CE.
    Clin Endocrinol (Oxf); 2021 Oct 01; 95(4):677-685. PubMed ID: 34231242
    [Abstract] [Full Text] [Related]

  • 12. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY, Park HD, Kim JW, Oh HJ, Yang JS, Chang YS, Park WS, Lee SY.
    J Perinat Med; 2014 Jan 01; 42(1):121-7. PubMed ID: 23989111
    [Abstract] [Full Text] [Related]

  • 13. Development and evaluation of a candidate reference measurement procedure for detecting 17α-hydroxyprogesterone in dried blood spots using isotope dilution liquid chromatography tandem mass spectrometry.
    He Z, Dai H, Shen J, Huang Y, Liu J, Yan R, Zhang F, Yan S.
    Anal Bioanal Chem; 2024 Aug 01; 416(20):4635-4645. PubMed ID: 38949681
    [Abstract] [Full Text] [Related]

  • 14. A MinION-based Long-Read Sequencing Application With One-Step PCR for the Genetic Diagnosis of 21-Hydroxylase Deficiency.
    Adachi E, Nakagawa R, Tsuji-Hosokawa A, Gau M, Kirino S, Yogi A, Nakatani H, Takasawa K, Yamaguchi T, Kosho T, Murakami M, Tajima T, Hasegawa T, Yamada T, Morio T, Ohara O, Kashimada K.
    J Clin Endocrinol Metab; 2024 Feb 20; 109(3):750-760. PubMed ID: 37804107
    [Abstract] [Full Text] [Related]

  • 15. Advancement in steroid hormone analysis by LC-MS/MS in clinical routine diagnostics - A three year recap from serum cortisol to dried blood 17α-hydroxyprogesterone.
    Gaudl A, Kratzsch J, Ceglarek U.
    J Steroid Biochem Mol Biol; 2019 Sep 20; 192():105389. PubMed ID: 31158444
    [Abstract] [Full Text] [Related]

  • 16. Steroid Profiling in the Amniotic Fluid: Reference Range for 12 Steroids and Interest in 21-Hydroxylase Deficiency.
    Pourquet A, Teoli J, Bouty A, Renault L, Roucher F, Mallet D, Rigaud C, Dijoud F, Mouriquand P, Mure PY, Sanlaville D, Ecochard R, Plotton I.
    J Clin Endocrinol Metab; 2023 Apr 13; 108(5):e129-e138. PubMed ID: 36402139
    [Abstract] [Full Text] [Related]

  • 17. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.
    Monostori P, Szabó P, Marginean O, Bereczki C, Karg E.
    Horm Res Paediatr; 2015 Apr 13; 84(5):311-8. PubMed ID: 26397944
    [Abstract] [Full Text] [Related]

  • 18. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry.
    Lacey JM, Minutti CZ, Magera MJ, Tauscher AL, Casetta B, McCann M, Lymp J, Hahn SH, Rinaldo P, Matern D.
    Clin Chem; 2004 Mar 13; 50(3):621-5. PubMed ID: 14656905
    [Abstract] [Full Text] [Related]

  • 19. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
    Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P, Matern D.
    J Clin Endocrinol Metab; 2004 Aug 13; 89(8):3687-93. PubMed ID: 15292289
    [Abstract] [Full Text] [Related]

  • 20. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
    Güran T, Tezel B, Gürbüz F, Selver Eklioğlu B, Hatipoğlu N, Kara C, Şimşek E, Çizmecioğlu FM, Ozon A, Baş F, Aydın M, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2019 Feb 20; 11(1):13-23. PubMed ID: 30111524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.